Assessment of risk of overall and late distant recurrence by Breast Cancer Index in postmenopausal women with early-stage, HR plus breast cancer in the TEAM trial.

被引:0
|
作者
Bartlett, John M. S.
Xu, Keying
Wong, Jenna
Pond, Gregory Russell
Zhang, Yi
Spears, Melanie
Salunga, Ranelle C.
Mallon, Elizabeth
Taylor, Karen J.
Hasenburg, Annette
Markopoulos, Christos
Dirix, Luc Yves
Seynaeve, Caroline M.
Van de Velde, Cornelis J. H.
Rea, Daniel William
Schnabel, Catherine A.
Treuner, Kai
Bayani, Jane
机构
[1] Univ Edinburgh, Canc Res UK Scotland Ctr, Edinburgh, Midlothian, Scotland
[2] Unity Hlth Toronto, Toronto, ON, Canada
[3] A Holog Co, Biotheranost, San Diego, CA USA
[4] McMaster Univ, Hamilton, ON, Canada
[5] Ontario Inst Canc Res, Toronto, ON, Canada
[6] Dept Pathol, Glasgow, Lanark, Scotland
[7] Univ Med Ctr Mainz, Mainz, Germany
[8] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece
[9] GZA Ziekenhuizen Antwerpen Campus Sint Augustinus, Antwerp, Belgium
[10] Erasmus MC, Kanker Inst Locatie Daniel Hoed, Rotterdam, Netherlands
[11] Leiden Univ Med Ctr, Leiden, Netherlands
[12] Univ Birmingham, Canc Res UK Clin Trials Unit CRCTU, Birmingham, W Midlands, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
509
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Validation of the Breast Cancer Index (BCI) prognostic models optimized for late distant recurrence in postmenopausal women with early-stage HR plus breast cancer in the TEAM trial
    Bartlett, John M. S.
    Xu, Keying
    Wong, Jenna
    Pond, Gregory R.
    Zhang, Yi
    Spears, Melanie
    Salunga, Ranelle
    Mallon, Elizabeth
    Taylor, Karen J.
    Hasenburg, Annette
    Markopoulos, Christos
    Dirix, Luc
    Seynaeve, Caroline
    van de Velde, Cornelis J. H.
    Rea, Daniel
    Schnabel, Catherine A.
    Treuner, Kai
    Bayani, Jane
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [2] Prognostic performance of Breast Cancer Index (BCI) in postmenopausal women with early-stage HR plus breast cancer in the TEAM trial
    Bartlett, J. M.
    Xu, K.
    Wong, J.
    Pond, G.
    Zhang, Y.
    Spears, M.
    Salunga, R.
    Mallon, E.
    Taylor, K. J.
    Hasenburg, A.
    Markopoulos, C.
    Dirix, L. Y.
    Seynaeve, C.
    van de Velde, C.
    Rea, D.
    Schnabel, C. A.
    Treuner, K.
    Bayani, J.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S602 - S602
  • [3] Prediction of early and late distant recurrence in early-stage breast cancer with Breast Cancer Index
    Zhang, Yi
    Schnabel, Catherine A.
    Schroeder, Brock
    Jerevall, Piiha-Lotta
    Jankowitz, Rachel Catherine
    Stal, Olle
    Brufsky, Adam
    Sgroi, Dennis
    Erlander, Mark G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Evaluation of the Breast Cancer Index in premenopausal women with early-stage HR plus breast cancer in the SOFT trial
    O'Regan, Ruth
    Zhang, Yi
    Fleming, Gini F.
    Francis, Prudence
    Kammler, Roswitha
    Viale, Giuseppe
    Lang, Istvan
    Ezquerra, Meritxell Bellet
    Bonnefoi, Herve R.
    Loi, Sherene
    Colleoni, Marco
    Schnabel, Catherine A.
    Treuner, Kai
    Regan, Meredith
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [5] A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR+ Early-Stage Breast Cancer with One to Three Positive Nodes
    Zhang, Yi
    Schroeder, Brock E.
    Jerevall, Piiha-Lotta
    Ly, Amy
    Nolan, Hannah
    Schnabel, Catherine A.
    Sgroi, Dennis C.
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (23) : 7217 - 7224
  • [6] Breast Cancer Index Identifies Early-Stage Estrogen Receptor-Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
    Zhang, Yi
    Schnabel, Catherine A.
    Schroeder, Brock E.
    Jerevall, Piiha-Lotta
    Jankowitz, Rachel C.
    Fornander, Tommy
    Stal, Olle
    Brufsky, Adam M.
    Sgroi, Dennis
    Erlander, Mark G.
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (15) : 4196 - 4205
  • [7] Breast Cancer Index and comparative analysis of late distant recurrence risk with results from the TEAM trial
    Bartlett, John M. S.
    Zhang, Yi
    Pond, Gregory
    Wong, Jenna
    Xu, Keying
    Spears, Melanie
    Mallon, Elizabeth
    Taylor, Karen
    Hasenburg, Annette
    Markopoulos, Christos
    Dirix, Luc
    Seynaeve, Caroline
    van de Velde, Cornelis J. H.
    Rea, Daniel
    Brufsky, Adam
    Stal, Olle
    Sgroi, Dennis
    Schnabel, Catherine
    Treuner, Kai
    Bayani, Jane
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [8] Cost effectiveness of letrozole versus anastrozole in postmenopausal women with HR plus early-stage breast cancer
    Lipsitz, Michael
    Delea, Thomas E.
    Guo, Amy
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (10) : 2315 - 2328
  • [9] Predictors of early recurrence in postmenopausal women with ER plus early stage breast cancer
    Mansell, J.
    Monypenny, I. J.
    Skene, A. I.
    Abram, P.
    Gattuso, J.
    Abdel-Rahman, A.
    Wilson, C. R.
    Angerson, W. J.
    Doughty, J. C.
    [J]. EJC SUPPLEMENTS, 2007, 5 (03): : 10 - 10
  • [10] Clinical utilization of Breast Cancer Index (BCI) for late recurrence risk assessment and prediction of extended endocrine therapy (EET) benefit in early stage HR plus breast cancer.
    Mahtani, Reshma L.
    Gadi, Vijayakrishna K.
    Operana, Theresa N.
    Soifer, Harris S.
    Schroeder, Brock
    Schnabel, Catherine A.
    Schwartzberg, Lee Steven
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35